Zhejiang Hisun Pharmaceutical Co.,Ltd.’s Net Profit Rose 35% in First Half of 2023

Zhejiang Hisun Pharmaceutical Co.,Ltd. (浙江海正药业股份有限公司) (600267.SH) reported a net profit of 431.1 million yuan in the first half of 2023, up 35% year-on-year.

Meanwhile, the company posted 6.1 billion yuan in revenue, up 5.6% year-on-year.

At the end of the reporting period, it had 18.3 billion yuan in total assets and 9.4 billion yuan in total liabilities, with a liability-to-asset ratio of 51.5%.